ANZUU — Envoy Medical Income Statement
0.000.00%
Last trade - 00:00
- $71.70m
- $74.26m
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Total Revenue | 0 | 0 | 0 |
Other Operating Expenses | |||
Total Operating Expenses | 0.001 | 5.2 | 4.89 |
Operating Profit | -0.001 | -5.2 | -4.89 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -0.001 | -0.252 | 20.7 |
Provision for Income Taxes | |||
Net Income After Taxes | -0.001 | -0.252 | 19.2 |
Net Income Before Extraordinary Items | |||
Net Income | -0.001 | -0.252 | 19.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -0.001 | -0.252 | 19.2 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0 | -0.005 | 0.362 |
Dividends per Share |